Innovation
is our nature

Discover our research

Exscalate: the future is already here

One of the most powerful intelligent supercomputing platforms in the world

discover more

Nathalie Dompé awarded with Visionary Award

Corriere della Sera celebrates Nathalie Dompé, co-ceo of Dompé pharmaceuticals, as the first Italian to receive the Visionary Award from Women Corporate Directors, the leading global network for women leadership.

discover more

Sunshine Act: more transparency in healthcare

On 11th June, the Italian Sunshine Act dedicated to healthcare, is finally in force. This provision contains new measures on the transparency of relations between companies, individuals operating in the health sector and health organizations.

discover more

Drug Discovery

Dompé farmaceutici has seized the potential of bioinformatics by developing various drug discovery platforms.

Dompé in the media

Read the articles

Neurotrophins

Our therapy based on Cenegermin Nerve Growth Factor has been awarded Breakthrough Therapy designation by the FDA and has received marketing authorization in Europe, the US, and China.

discover more

We are hiring

People: our most valuable asset. That’s why we promote their professional development.

CHECK OUT OUR OPEN POSITIONS

Pipeline

With our research and development pipeline, we target some of the highest-needing therapeutic areas.

Dompé Foundation

We nurture and develop talent to push the boundaries of knowledge further

discover more

Research, development and production contributing to innovation

Alongside our manufacturing activities, our hub in L’Aquila also accommodates a number of research facilities covering the whole Drug Discovery process for small molecules and biotech drugs, from the early stage to clinical development and patient administration.

Discover our production hub

8 production lines

7 synthesis, 1 biotech

60 million

manufactured packages per year

CDMO facility

synthesis and biotech

27 clinical trials

over 200 patients

Dompé logo

Dompé farmaceutici S.p.A. Single shareholder company / Share capital € 50.000.000,00
REA MI 289519 - A registered company in Milan, Italy / Tax code and VAT number IT00791570153

Close